INDUSTRY WATCH: January/February 2015
Kirby Lester has found that the
reclassification of hydrocodone as a Schedule II drug by the U.S. Drug
Enforcement Agency caused a spike in demand for the company’s KL1 and
KL1Plus tablet counting devices. The use of these devices to double-count
Schedule II prescriptions makes this a more efficient process.

Advertisement